OVERWEIGHT OR OBESITY
Clinical trials for OVERWEIGHT OR OBESITY explained in plain language.
Never miss a new study
Get alerted when new OVERWEIGHT OR OBESITY trials appear
Sign up with your email to follow new studies for OVERWEIGHT OR OBESITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New obesity drug REGN20934 enters first human safety trial
Disease control Not yet recruitingThis Phase 1 study tests a new drug called REGN20934 in 90 adults who are overweight or obese. The main goal is to check the drug's safety, side effects, and how the body processes it. Participants receive a single dose of either the drug or a placebo, and researchers monitor the…
Matched conditions: OVERWEIGHT OR OBESITY
Phase: PHASE1 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New obesity drug SYH2082 enters first human safety trial
Disease control Not yet recruitingThis Phase 1 study tests a single dose of SYH2082 injection in 44 healthy adults who are overweight or have obesity. The main goal is to check safety and side effects, not weight loss. Participants will receive either the drug or a placebo, and researchers will monitor how the dr…
Matched conditions: OVERWEIGHT OR OBESITY
Phase: PHASE1 • Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New Weight-Loss shot enters first human safety trial
Disease control Not yet recruitingThis early-stage study tests an experimental drug called CMS-D008 in 110 healthy and overweight or obese adults. The main goal is to check safety and how the body processes the drug, not weight loss. Participants will receive either the drug or a placebo as injections, and resear…
Matched conditions: OVERWEIGHT OR OBESITY
Phase: PHASE1 • Sponsor: Shenzhen Kangzhe Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New pill could help shed pounds without surgery
Disease control Not yet recruitingThis study tests an experimental oral drug called MDR-001 to help adults with overweight or obesity lose weight over 52 weeks. About 738 participants will receive either the drug or a placebo, along with lifestyle advice. The main goal is to see if the drug leads to meaningful we…
Matched conditions: OVERWEIGHT OR OBESITY
Phase: PHASE3 • Sponsor: MindRank AI Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC